Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
4(27%)
Results Posted
29%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph early_phase_1
1
7%
Ph phase_2
3
20%
Ph not_applicable
3
20%
Ph phase_1
3
20%
Ph phase_3
1
7%
Ph phase_4
3
20%

Phase Distribution

4

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
3(21.4%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Active, not recruiting2
Recruiting2
Terminated1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.1%)
Phase 13 (21.4%)
Phase 23 (21.4%)
Phase 31 (7.1%)
Phase 43 (21.4%)
N/A3 (21.4%)

Trials by Status

terminated17%
withdrawn17%
active_not_recruiting213%
completed747%
not_yet_recruiting17%
recruiting213%
unknown17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07227649Phase 2

NAC-REPAIR for Post-surgical Pain

Not Yet Recruiting
NCT07155044

A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma

Active Not Recruiting
NCT05485558Phase 2

the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy

Completed
NCT06367413Not Applicable

Effects of Protein and NAC Co-ingestion on Skeletal Muscle Recovery

Recruiting
NCT01878344Phase 3

Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

Active Not Recruiting
NCT05509153Phase 2

A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

Recruiting
NCT06252519Not Applicable

Pharmacokinetic Profile of N-Acetyl Cysteine

Completed
NCT04693949Not Applicable

Effect of Nano-structured Alumina Coating on the Bond Strength of Zirconia Resin-bonded Fixed Dental Prostheses

Unknown
NCT03121989Phase 1

Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Withdrawn
NCT01896492Phase 4

Clomiphene Plus N-acetyl Cysteine for Induction of Ovulation in Newly Diagnosed Pcos.

Completed
NCT01241513Phase 4

Induced Changes in Ventilatory Responsiveness and Altitude Exposure

Terminated
NCT01852825Phase 1

MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)

Completed
NCT03534115Early Phase 1

NAC Prevents Toxicity of Teeth Bleaching

Completed
NCT02483143Phase 4

NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial

Completed
NCT02259595Phase 1

Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC

Completed

All 15 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
15